While increased iNOS expression in the airways is thought to be the main cause of higher FENO levels in patients with asthma, most studies report similar or only slightly increased FENO levels in COPD patients despite increased nitrosative stress in these patients [8, 11–14]. Here, NOS2 is linked to chronic obstructive pulmonary disease.